Q4 2020 Berry Global Group Inc Earnings Call
[music].
Ladies and gentlemen, thank you for standing by and welcome to the Berry Global earnings Conference call at.
At this time all participants lines are in a listen only mode.
After the speaker's presentation, there will be a question and answer session.
Ask a question during the day session you will need to press star one on your telephone please.
Please be advised that todays conference is being recorded.
If you require any further assistance please press star zero.
And I like to hand, the conference over to your speaker today Dustin Stilwell. Thank you. Please go ahead Sir.
Thank you and good morning, everyone welcome to Berry fourth fiscal quarter 2020 earnings call.
Throughout this call we were reported in the fourth fiscal quarter on September 2020 corridor.
Before we begin our call on like you mentioned that on our website, we provided a slide presentation and help drive and discussion this morning.
After today's call a replay will also be available on our website and Barry <unk> Dot com under our Investor Relations section.
Joining me from the company I have Berry, Chief Executive Officer, Tom Salmon and.
Chief Financial Officer, Mark miles.
Oh, and told and Mark's comments today.
Sure and answer session in order to allow everyone the opportunity to participate and you out and you limit yourself to one question on time, and then fall back into the queue for any follow up for additional questions.
As referenced on slide two during this call, we will be discussing and non-GAAP financial measures and.
Most directly comparable GAAP financial measures.
And a reconciliation of the differences between the GAAP and non-GAAP financial measures are available on our earnings release and Investor presentation on our website.
And finally, a reminder that certain certain statements made today maybe forward looking statements. These statements are made based upon management's expectations and beliefs concerning future events impacting the company and.
Therefore involve a number of uncertainties and risks, including but not limited to those described in our earnings release annual report on form 10-K, and other filings with the FCC.
Therefore, the actual results of operations and financial condition of the company could differ materially from there.
It's expressed or implied in our forward looking statements and now I'm going to turn the call over to Berry CEO Tom Salmon.
To dust and welcome everyone and thank you for being with US today to discuss Berry September quarter and full fiscal year results.
First I want to take this opportunity to welcome Joe Romit to our board of Directors Jos currently Chief operating officer of the Greater Chicago Food Depository.
Your past experience at Kraft and Conagra and packaging brand management.
Marketing and strategic planning and she brings a perspective and experience to our board of directors that will be very beneficial to our company.
Reflecting on fiscal 2020, we had a terrific year, despite unprecedented market conditions, and while integrating our largest ever transformational acquisition.
I would like to give special thank you out to our entire Berry team across the globe.
And we are essential frontline team members for their dedication and helping us achieve record financial results and for me the critical needs of our communities and customers and this challenging environment.
Helping keep each other safe.
The resiliency and defensive nature of our end markets was clearly evident this year and the execution on the things that we can control was exceptional.
Moving now to slide three.
As we've noted our key strategic priorities and fiscal 2020 were one and generate profit organic growth.
Secondly to integrate the business acquired with RPC and third further.
Further strengthen our balance sheet.
I'm very pleased to report success and all three priorities in fiscal 2020.
First as Mark will provide more in detail, we generate a better than expected quarterly and full year organic volume growth.
With regard to the second priority. The RPC integration is progressing better than plan, including realized cost synergies, which were 17% higher than expected and fiscal 2020 and.
Additionally, we continue to develop and long term global commercial strategies, and we expect to benefit on for years to come.
Third we made significant progress towards lowering our leverage by a half a turn in fiscal 2020, ending the year at 4.3 times net debt to adjusted EBITDA.
And lastly, we're encouraged by organic growth pipeline and are well positioned to continue to deliver solid and sustainable organic volume growth through the development and focused on our growing end markets through strategic expansion into emerging markets and true growth opportunities driven by sustainability, all well being and the substrate that is.
Growing and their offers superior characteristics, such as a barrier chronic safety durability clarity designed versatility and the lowest carbon footprint.
Now I will move to our number one core value on slide four and that is safety.
We fully understand and what we do here at Berry is a valuable part and the supply chain make and supply and products that are protect and each other our friends our families and our neighbors and communities around the globe, our number one priority and core values to health and safety of our team members.
We believe safety doesn't happen by accident and everything we do at Berry starts with safety.
And you can see on the slide we have an ongoing commitment to identify and managing and eliminating risk and are very proud of our safety record and then osha recordable incident rate significantly better than the industry average.
Turning now to a few highlights of our financial results on slide five.
And the September quarter, we delivered 4% organic volume ahead of our already upgraded guidance with the full year, delivering 2% organic volume growth.
Additionally, on the quarter operating EBITDA increased by 18% to $586 million and for the full year increased by 41% to a fiscal year record of $2.157 billion and finally adjusted earnings per diluted share grew an impressive 42% versus the prior year.
$4.85.
These strong financial results on a byproduct of our entire global teams focus on organic growth opportunities and driving cost productivity.
Now I will turn the call from Mark Who'll review Berry's financial results in more detail Mark.
Thank you Tom I Wonder from one of the slide six.
That's cool fourth quarter reported sales were just over $3 billion. The corner revenue included organic volume growth and 4%, partially offset by the pass through from lower resin prices to our customers and the sale of our seal for life business.
From an earnings perspective, the September quarter operating EBITDA increased by 18%.
Quarterly record of $586 million.
All four segments growth organic EBITDA in the quarter and putting contribution from synergy realization.
Cost productivity and the benefit from organic volume growth.
Adjusted EPS increased by 77% to one dollar and 59 cents from the quarter, which included benefits just referenced relating to EBITDA and along with interest expense savings from debt reduction of over $1 billion and fiscal 2012.
Looking at our fiscal year highlights we achieved record for nearly every key financial metrics, including $11.7 billion and net sales operating EBITDA of $2.157 billion and adjusted EPS on a $4.85.
As a reminder, we do not add back amortization of intangibles from acquisitions.
Which would increase our EPS by over $1.50 sounds and we believe this should be considered when comparing berry to other companies that make this adjustment.
Additionally, we significantly surpassed our free cash flow guidance generating $947 million and free cash and 24% increase versus fiscal 2019.
These results are driven by the outstanding effort from our entire global team.
On an unprecedented pandemic and while integrating the RPC business.
These results are yet. Another example, and you can see on slide seven of our proven performance over many different economic cycles.
We have consistently driven top tier results and key financial metrics, including 20% compounded annual growth rates from both free cash flow and adjusted EPS.
Now looking on the quarterly performance on each of our four operating segments on slide eight.
Order, our consumer packaging International Division delivered sales of just under $1.1 billion and EBITDA of $202 million.
And the quarter volumes were up 1% from.
And from strength and consumer centric end markets, partially offset by some COVID-19 related headwinds and industrial markets.
We are encouraged by the positive volume results and are optimistic given the pipeline built and momentum and the business.
The CP VI team delivered an impressive 17% increase and EBITDA, what cost synergy realization positive product mix and cost productivity.
Net sales and our consumer packaging North American division were $746 million.
6% increase and organic volumes offset by the pass through of lower resin prices.
The 6% organic volume on the quarter was ahead of our expectations provided on our last earnings call. As we have continued to strengthen our core consumer businesses from products, such as closures bottles and containers.
EBITDA was $160 million compared to the $137 million from prior quarter and 17% increase was primarily driven by the strong volumes on the quarter and cost productivity, including synergies from the RPC acquisition.
Our health hygiene, and specialties division delivered sales of $604 million.
The 6% increase included organic volume growth, 12% with growth and all four regions globally, partially offset by the pass through from lower resin prices and the sales of the seal for life business.
Segment volume were up high.
High single digits, primarily related to organic growth investments.
But the balance benefiting from the additional demand for health care products.
EBITDA increased by $35 million and were 42% when adjusted for the sale to seal for life business. This improvement.
That was driven by the organic volume growth favorable product mix and cost productivity.
And lastly sales from our engineered materials division were $587 million. A decrease was primarily attributed to pass from lower resin prices and a modest 1% decline and volume.
As anticipated our engineered materials segments, all sequential demand improvement compared to fiscal Q3.
Growth in our consumer facing and some of our industrial businesses.
Were offset by weakness and our can liner business that serves away from home waste disposal.
EBITDA grew 5% over the prior year quarter and the team delivered strong cost productivity.
Next on slide nine on.
Free cash flow from the fiscal year with an annual record of $947 million and improvement of $183 million from 24% compared to the prior year, driven by our growth and EBITDA, partially offset by higher capital expenditures.
As free cash flow was utilized to reduce our outstanding debt by over $1 billion and fiscal 2020.
Lowered our annual interest expense by over $50 million and reduce our debt leverage from 4.8 times to 4.3 times.
We remain committed to maintaining a strong balance sheet.
And our consistently increasing and dependable cash flow provides us the opportunity to further improve our strong balance sheet as we have demonstrated historically.
And our fiscal year 2021, operating EBITDA and free cash flow guidance as shown on slide 10.
We're targeting operating EBITDA of $2.15 billion to $2.2 billion, and free cash flow and $875 million to $975 million.
The range of free cash flow includes 1.525 billion to $1.625 billion of cash flow from operations.
And capital expenditures of $650 million.
Capital expenditure plan as a nearly $70 million increase from our fiscal 2020 spending as a result from our growing pipeline of customer linked growth projects.
Excluding the incremental growth capital our fiscal year 2021 free cash flow is expected to exceed $1 billion.
This guidance also considers the divestiture of our U.S. flexible packaging converting business, which we have assumed is completed and the first fiscal quarter of two and 2021.
This business generated approximately $25 million from operating EBITDA and fiscal 2020.
We expect another year of organic volume growth of 2%, which is supported by a robust and growing pipeline increased level of capital expenditures and the positive trends and momentum we are seeing and each of our businesses.
We also anticipate further strengthening our balance sheet fiscal 2021, and expect our leverage ratio to close between 3.8 and.
3.9 times at the end of fiscal 2021, consistent with our previously committed target of below four times post the RPC acquisition.
This concludes my financial review and I'll turn it back to Tom.
Thank you Mark.
Our economic resiliency and durability has proven true as it has and past challenge economic periods.
Global 19, as anticipated has impacted our global businesses. However, due to our diverse and stable portfolio. We have grown volumes the face of these challenges on.
I'm very confident in our teams ability to meet our near term and long term expectations and commitment to provide sustainable profitable growth.
Across our company our teams are performing at a high level with an exceptional sense of urgency to demonstrate organic volume growth by providing an advantage products and targeted markets and evidence in our quarterly and fiscal year end results.
On slide 11, you.
You can see some of the key drivers for organic growth and why we feel confident in our continued trajectory.
First we continue to pivot our portfolio and focused investments on faster growing end markets and global Mega trends.
Over the past several years, we have worked diligently to increase our exposure to these areas. We will continue to focus on collaboration with our global customers to meet their growth and innovation objectives.
In order to further accelerate a grant and growth across our global footprint. We've made some small business movements between our segments at the beginning of fiscal 2021.
These changes allow us to create a global rigid health care packaging and device business in order to maximize our global customer relationships manufacturing and technology no on.
Our total global health care business has grown from $500 million and 2015 to now over $1 billion and revenue.
Additionally trends such as health and wellness food safety and E. Commerce continued to be growing opportunities for each of our businesses.
We are supporting these trends by allocating resources and capital and products such as clean room medical packaging to support the biopharmaceutical markets enhance barrier products to keep fresh food fresh longer and increased resources to serve the growing ecommerce lifestyle just to name a few.
Secondly, through investment and acquisition, we've enhanced our portfolio and have moved into faster growth emerging markets emerging markets, such as Asia, South America, Mexico Africa, and Eastern Europe.
Offering higher growth potential, including scale ability to manufacture products with stable demand.
Since 2013, we increased revenue on these faster growth regions from $100 million to now over $1.5 billion.
Through acquisition and organic investments, we now have 295 facilities around the world with a wide mix and technologies to meet the needs of our global customers third.
Third our substrate continued to provide many benefits that no other substrate can match plastic.
Classics offers the advantages of lighter weight clarity designed versatility durability, along with the lowest carbon footprint compared to other substrates for this reason plastics is taken considerable share over the past 50 years and is expected to continue to grow for years to come.
And lastly, turning to slide 12, obviously sustainability from which we have long considered to be cord and various operating philosophy. The industry has taken tremendous steps forward and the journey to eliminate plastics waste, while continuously innovating to meet desired performance requirements of consumers.
Over the past several quarters Berry has worked closely with industry leaders and partners across the value chain, including weight management companies resin producers and brand owners, along with Ngls to improve the circularity of our products.
With our global footprint and scale, we've entered into offtake agreements for recycled materials globally, and and also expanded our on recycling operations in the U.S. and <unk> and Europe to help our customers meet their sustainability goals.
Additionally, you can see the significant benefits by using plastics over other substrates benefits during the manufacturing process, such as using six times less water producing five times less waste, while generating two times less greenhouse gas emissions.
With the increased effort to create a more circular economy through the use of more recycled materials lightweighting re formulation and tagging and identification, we see a strong and growing opportunity to provide product that not only provides the best customer experience with superior characteristics, but one that will have the smallest impact on the environment.
On slide 13, we highlighted a few of the main products, we design with sustainability mine just this year. Our films group was awarded the flexible packaging Achievement award for their design and Kellogg's and bear naked Granola recyclable standup pouch.
This new power not only met the customer expectations.
What was lighter weight recyclable and improve the shelf life of the product and.
Additionally, we partner with my delays for their Philadelphia cream cheese product to provide a package made from advanced recycling material to achieve our common sustainability goals.
Furthermore, during the year, we were awarded and exciting paper to plastic conversion win of Conagra's Swiss Miss Hot Chocolate, New easy group container.
This converse and includes a net double space efficient taper design.
These are just a few of the highlights on the exciting products on that exhibit our development and intense focus on improving the recyclability, the reuse and reduction and plastics all with the goal to promote and more circular economy.
And finally on slide 14.
To summarize we had an outstanding fiscal year meeting or surpassing every financial and strategic target. We set out all while working through one of the most unique and unprecedented markets we've ever seen we.
We delivered on all three key strategic goals, we set forth for the fiscal year organic growth and proven our balance sheet and integrating the RPC acquisition.
In addition, we set financial records for EBITDA free cash flow revenue and earnings per share.
We entered fiscal 21.
Both enthusiasm and confidence and our ability to grow organically as we've demonstrated this past year.
I believe we are well positioned to see long term predictable and sustainable growth with customer link capital investments that target continued expansion and both faster growing end markets and emerging markets.
I. Thank you for your continued interest and Berry and at this time, Mark and I'll be happy to answer any questions you may have.
As a reminder to ask a question you need to press star one on your telephone.
Are your question press the pound key.
Please standby well, we compiled acuity roster.
And your first question comes from Iran. This one thing with RBC capital markets.
All right. Thanks for taking my question.
Congrats on the great results and fiscal 2020, yes, I guess I just want to start there I'm just on the free cash flow, maybe you could help us understand what drove the significant upside and and 20, a little bit more and then also the bridge to 21.
Is it possible that you could potentially hit the upper end of that that range 975, if resin prices moderate or and stabilize a little bit here. Thanks.
Yes. Thanks.
So a number of factors I would just point to one thing that over growth and cash certainly volumes earnings contributed on capital expenditure timing of.
Of the spend the jurors actually also benefited from fiscal 2020, as we had targeted over 600 million of capital on that that came and under 600 interest expense also saw tailwinds of lower interest rates benefited the company.
And then certainly working capital I think the teams done a great job on continuing to drive working capital efficiency within the company. So I can't point to one thing it was multiple factors that drove.
Outperformance and 20 and with respect to 21, yes, certainly I mean, we gave a range and we're going to work hard to do everything we can to maximize.
On the key financial metrics.
But the company follows on tracks and putting cash flow.
Your next question comes from and Jim.
Punjabi with Baird.
Hey, guys good morning.
Yeah.
Yes, looking back at fiscal year 20, how much of the 2% core volume growth came from your new products and aggregate versus you know and he estimated cobot benefit theres lot going on with the end markets et cetera. What do you think that number was for Fourq you specifically and then as you think about fiscal year 21, and how will your guided towards 2% volume growth kind of play out on a cash.
On the bases I mean, obviously you comparisons will get tougher during the back half of 21. So any visibility you can share on the layering of a few products would be helpful. Thanks, So much.
Gunshot we've been really for several years now focused on three primary areas of investment for the company and we feel that investing around those larger mega trends with customer link partners is going to generate the most benefit for the company now that being health and wellness that being.
Food safety and preservation, keeping fresh food fresh longer E commerce as well as all of those are ultimately.
Guided by our our look towards any opportunities to enhance our sustainability position and footprint. So the majority of the growth continues to be around those three buckets and those three categories and.
For 2020, clearly the business generated.
Very strong.
Mid single digit low single digit growth as as was reported and 421. We similarly expect that we'll we'll deliver that low single digit growth in <unk> and the business.
In aggregate still for our entire portfolio, you mentioned cobot Cobranded day, a flat to slightly positive impact.
To our business you know the offset to that clearly is on the impact that koby can have on some of the industrial base businesses, but we really feel that the portfolio is as resilient as ever.
Demonstrated in in 2020 and gives us a great deal of confidence going forward into 21, and its really guided by the strength of the target positions that we built in all four of our businesses and the momentum that they are accepting 2020 gives us a good deal of confidence and 21.
Your next question comes from George Staphos with Bank of America.
Hi, guys. How are you congratulations on the progress and and 20 and.
I hope, you're all doing well first.
First question for you Tom more of a bigger picture picture question and some around sustainability, which.
The Companys all fired up on so you know greenhouse emission and Theres PCR usage and there's lightweighting.
There's recyclability from the work you've done.
And the work Youre customers have done what is the single most importantly, and sustainability attribute to the consumer.
And what are you then doing and terms of marketing.
For product development around that metric and then I had a follow.
A follow on related to one of the businesses.
It's a great question and you could probably ask a variety of different people you might get different responses, but it literally came up yes.
This past week and one of our business reviews.
And our end users continue to value the attributes of plastics.
And what they're looking for as different ways that we ultimately could impact no the weight.
The material that goes into providing them a viable solution that doesn't compromise physical properties to help them meet that objective and that continues and you know and our long history that has been a value that Berry has brought for many many years and find new ways to control.
And you do improve and optimize design and that continues to be for our end users that were exposed to.
One of the most important sustainability attributes that we can bring to them.
We are clearly.
Leveraged across the variety of outcomes in terms of sustainability, we referenced the investments that we're making and North America as well as Europe around.
Around mechanical recycling, we've talked about the offtake agreements that we've established to make certain that we have access to advanced recycling materials. So we can introduce those to wear and customers. We've delivered on those and we're closing applications and those materials, we've talked about ways like from Georgia Pacific.
And that we can demonstrate a true circular economy, and we're doing that but so we feel really good about where we're at in terms of that journey. It's still in the early stages, but at this point plastics continues to be valued our end users want to know how again, we can continue to optimize design to me.
Maintain functionality, while not compromising.
No the integrity of on the attributes and looking for whether its clarity whether it's whether it's barrier properties.
Whatever the case may be and in the average all from me reduce weight.
It's interesting Tom So recyclability isn't sort of key to the consumer on that it sounds like it goes hand in hand, because the design always must incorporate did they designed for sustainability. So they're accomplishing two objective objective one is ultimately.
Optimize and design functionality, while using less option two and component that's expected as the year before incorporating sustainability concepts in that in that design. So it can be more function on to recycle.
Got it got it I wanted to go back to some of the questions that are that are grown and gone from teed up and more to the extent that you can comment more specifically on health hygiene specialties I would just want to make sure I understood.
So I thought you said that your growth.
In the quarter.
Or New York and it was about high single digits and the remaining amount that got you to the 12% was the health care, what we'll call. It the health care balance from coded did I hear that correctly that I mischaracterize anything and considering that and considering the high single digit growth that you got from.
And that's on a secular basis does that.
That mean that we're looking at pretty flattish growth and 2021, just because the comps are high quality problem or are so strong. Thank you guys and good luck on the quarter.
Thank you.
To give you I'll start on your last first for 21, our outlook is that our HHS business will be up low to mid single digits for fiscal 21.
As as you've heard US discussed we've made a conscious effort and that business to continue to retool and optimize the portfolio around higher growth components like premium hygiene, Fem care adult incontinence, as well and access to faster growth.
And reasons the world the team's done a fabulous job and executed against that and also the opportunity that we've had to further invest in areas and the health care space things like surgical drapes and gowns.
Had begun that translation and some of the developing regions of the world. So we feel really good about that so that business as we had originally outlined we thought that the business would be up and the on the.
Hi single or low single digit mid single digit pre coated.
And with Cold and ultimately has taken advantage of some of the versatility of our assets.
To print the number that it did and and in Q4 at 12% and it really it had and had a terrific.
2020 in aggregate the business is really well positioned we're more global than we've ever been we've got better penetration and a key accounts than we've ever had.
And the team's executing on a very high level.
Thank you Tom I will turn it over.
Your next question comes from Duffy Fischer with Barclays.
Yes, good morning, gentlemen.
Two questions around the 2% growth. So one has to do with the $93 million you call out in your guidance walk to next year. If you just you know 2% about $250 million at your margin that'd be about $45 million of uplift from volume does that imply that there's kind of cost of 45.
The $50 million that you'll get irrespective of what volumes do and then you just talked about HMS and kind of what the macro you expect there could you walk through the SB use within that 2% guide and just talk about the macros that you're putting over that for 2021.
Yeah. The first part of your question.
You got it exactly right the cost save our lack the annualization on things that happened in 20, but we didn't get a full year benefit so.
Only half of that 93 million actually and well over half is coming from that it's just cost synergies.
We're run rating and 2021.
And with respect to your second question.
Yes, all offshore businesses, our outlook is for them to continue to grow low.
No single digits.
And 21.
But I guess the question was more just right. What do you expect from the macro world to get to that 2% what could happen you know I mean.
Yes.
Yes, those two yeah, we're fortunate as Tom said, we've got a diversified portfolio.
Most of our products are 70% of our products for consumer everyday products food and beverage personal care household products.
And so were fortunate and we've got a diversified portfolio you can look through past economic cycles, our volumes remain very consistent from period to period.
And so I think the.
The macro while it's important I don't think it would significantly change our result, I think our unique component to it as well is we further globalize the business, which the benefit and we're exiting.
2020, with a more robust.
Target list by business than we had going into 2020 as an example, so gives us a great deal of confidence and as Mark said, the fact that the majority of our portfolio non discretionary gives us lot of confidence given that the target position for growth is greatly enhanced and 21.
Great. Thanks Fellows.
[music].
Your next question comes from Neel Kumar with Morgan Stanley.
Hi, good morning.
Whereas ctdna your 6% volume growth for the quarter came in well above your low single digit expectations.
Talk about the cadence and volume during the quarter price segment, and what led to the upside on how generally would you characterize and then transparently and foodservice space.
The cpnine.
Really strong franchise inside our company and just completed its third consecutive year of organic volume growth and and I were mined it typically inside a quarter you may see ebbs and flows and they had a very high hit rate of new business in the quarter, which was a plus.
Continued strength and the grocery space.
Very strong performance and closures dispensing solutions.
And relative to foodservice, it's continued to improve its it's a very it's on a very stable point right now.
As as the world's opened up in terms of kind of modified Reopenings. If you will.
We continue to see improvement inside that space, but across really all segments of CP in a theyre executing at a very high level. They continue to take advantage of this.
This trend some more at home consumption.
On that that frankly, many of our and customers believe is going to be sustainable.
But from the last three years, it's been it's been delivering and we clearly expect 2021 will be its fourth consecutive year of low single digit organic volume growth.
Your next question comes from Adam Josephson with Keybanc.
Thanks, Good morning, everyone and congrats on a really good end of the year.
The bark one question on guidance and then I have a sustainability question on the guidance can you just talk about your price cost assumption for the year I think.
On the appendix you talk about a $25 million ahead.
Because of resin costs time, Inc, which I presume will be mostly in the December quarter, but I think price cost was about an 85 million benefit for you and fiscal 20 are you assuming just a 25 million drag in fiscal 21 or something else and then related lead just the sequencing of EBITDA are you expecting any different mix in terms of one h. first.
As to age and normal just given that Reds and drag early on the year or not necessarily.
Yes on your.
On your first part.
Slide 16 on our.
Dec has kind of a layout of our bridge from our 2020 actual to our guide for 21.
Some of the.
First grow there and the synergies that we talked about when we report price cost some of that will show up and that price cost bucket.
And as you mentioned that next row with respect to the 25 million and that factors on timing lag on increases we've had on our primary raw materials.
And just plastic RASM or several months on consecutive increases on that market and.
And so we've built on some lag we have a very efficient pass through process from passing through revenue, but there has a slight modest timing lag on that.
Impact some of the December and there might be some trickle into March for some of the slower moving items.
But you've got that right.
And then the prior year mix benefit which is the next ROE that would also be on that price cost column.
The pivot the some of the health care products.
On rate and higher profits, we've got two quarters benefit and our fiscal 20 from that improved mix and our guidance. We've got one quarter open to the low end on the outlook for the expenses.
The world stays the same and this health care.
Demand increase precipitate beyond the first quarter, obviously that would push push on higher on the range with respect to that specific category.
On the guidance, but that would also impact.
On price mix, so kind of a net of that Adam short answer is and it's kind of a wash and it depends on how some of these.
Factors come in over the course of the year.
Perfect. Thank you Mark and Tom just on the sustainability topic with respect to the recycled content.
Specifically can you talk about how important that is to your customers in light of the pledges they've made I was looking at the.
The recent update of the progress report from L. and Macarthur Foundation, and you can see that all the CPG companies that have made these pledges to use call it 25% recycle.
Recycle content by 2025, and they're there and there are well below that target and most cases and I know.
Recycled rise and it is not.
And then and it's more expensive than than Virgin resin. So can you talk about that issue how important that is.
Relative to all the other issues you've talked about on the sustainability topic.
I think it continues to be front of mind, I think theres a number of ways to get there we can get there via mechanical recycling, we can get there the.
And in addition to the advanced recycling so the energy and effort around uses advanced recycling as a means by which to us to help them meet those goals and objective and at the same time help eliminate classics weight is is an exciting development I said about it in past calls the amount of collaboration.
From the industry around development of these technologies and know how is unprecedented and.
EBIT inside Berry as well, we're making more investments and in North America as well as Europe just to your point with a lot of the aggressive goals that are and customers are asking for around sustainable solutions.
And puts berry and unique position that we can offer materials that cover a range of.
Solutions, whether that bio based materials that we recently introduced this year, whether its sort.
Circular position opportunities, whether its incorporating mechanical means on materials were advanced recycling. So.
I think advance recycling and in my view is going to play a big impact that on that strategically and.
And we like the fact that we become very comfortable with the new introductions of capacity that have been introduced securing percentages of that so that we can work in collaboration with our end users to get them comfortable and successfully close more business like we did with mine to lead the degree.
For example, you know with a premier brand, eliminating the barriers of risk or concern and then ultimately having a successful launch so it's not going to be just one way that we get there I think mechanical and the infrastructure development is also going to be supported by the advanced recycling, which which is which is quite exciting.
And every every major resin company and the world.
In some form is focused on that and I'm also I I'd be remiss, if I didn't give a quick advertisement for the alliance and plastics waste, but theres and were from 11 to 15 different projects going on right now around the world.
Focused on infrastructure development education.
And monetize and demonstrate real monetize business models to ultimately scale and.
More of those to be introduced once we have the the data that you guys can scour and and review, but I'm pleased with the progress in that regard and certainly that will be something that and in due course, the alliance will be introducing as well but.
Long winded answer, but it's not a straight straightforward solution for sure sure. Thanks, a lot on.
Your next question comes from Josh Spector with DBS.
Yeah, Hey, guys. Thanks for taking my question.
You mentioned during the presentation and you have a slide of the Backfilling. Some of the segment realignment, you're creating some more global business lines and health care products and films I was wondering if you talk about how those business. We manage it met its differently is there any cost aspect that you would benefit from and or is it more growth driven and from the outside prospect.
When do you think we start to see some of the benefits and maybe that realignment. Thanks.
Yeah, the creation of our global rigid on.
Health care business is exciting we felt that.
Given the global nature of the business harmonized and that under one leadership organization on to be led by.
And mark as on of our CPI organization.
Would allow us ultimately to harness the non manufacturing technology and commercial know how relationships to.
To drive a better outcome in terms of growth faster.
Listen, we're we always look at one and other on a year over year basis. So.
And quote a number in terms of the improvement that we're targeting but we clearly believe on this.
This is an optimal way to manage that exciting growth category, which by the way is consistent with those mega trends, we've talked about that we can structure the business differently, not and not to focus on cost reduction, but to accelerate growth differentiation and innovation and I'm pleased with the collaboration.
With this global team residing obviously throughout the world.
And the progress, we're making in terms of their pipeline and opportunity with key end user. So it absolutely is is the right thing to do.
And I am excited about the prospects because it's it's a business that.
We feel has a lot of runway and is going to provide benefit for our company for years to come.
Your next question comes from Anthony Pettinari with.
Thanks.
Good morning.
On the debt on the divestiture of the flexible converting business I was wondering if you could talk about the rationale just quickly and maybe the margin and growth profile for that business.
And are there any additional businesses that could potentially be non core and then just generally on your comments and presentation and there's a big emphasis on organic growth, which is great and should we view various maybe potentially less interested in big acquisitions or bolt on still potentially attractive just any kind of comments sir.
Yeah, the business, we divested the lamination pretty flexible packaging business and serve both food and industrial markets.
And frankly, it allowed us to remove what was otherwise a channel conflict for our flexible packaging bill on portfolio, which had shown high single digit growth over the last few years.
Surprisingly not enough, but its supporting spaces like new ecommerce packaging stand up pouches barrier films and the likes where you heard US talk about I look at this move similar to what we did and our steel for like divestiture and again it is a key.
Consistent with our commitment to grow organically and in spaces that we deem is corn track and so.
And it's relatively minor minor divestiture.
I would not say listen Berry. It is our three strategic priorities, our balance sheet prudent and are delivering prop organic growth.
In 2020, and then and as well integrating RPC.
We're very fortunate to have an improving balance sheet.
And we have array of opportunities for us to deliver shareholder value and so I wouldn't say anything quote unquote is ruled out but our priorities and.
Clearly as you can see by our results and our outlook our continued to improve the balance sheet and deliver on the organic growth commitment and execution that we demonstrated in 2020 and 21 and beyond.
And continue to find ways to optimize what we do in terms of support these mega trends like like ecommerce health and wellness and food safety, So that's where you're going to see the ramp capital investment for that and we're very excited about the pipeline of opportunities that we have to do customer link.
And investments, where we're supporting our key end users, helping and pull through.
Exciting opportunities for demand and and we're excited about that net position. We think it's we think the teams are in a very good place. We're excited about where we're exiting 2020 from a pipeline perspective, and we feel confident that we will deliver on the commitments that we've outlined in terms of 21 for this call.
Okay. That's helpful. And then just quickly the investments that are driving that 70 million step up and Capex is it possible to to say how those are sort of roughly split up between the four segments or any sort of major projects you'd flagged that are driving that we've announced a couple of them.
And HHS, we've got a new $70 million health care line in China and.
Thats going on and that will support a health care and southeast Asia. So we're really excited about that but in general across all the businesses you are seeing investments that support health and wellness food safety preservation E Commerce, all with an overriding banner of sustainability.
And how we can use sustainability as a competitive tool to deliver profitable sustainable growth.
Okay, Great that's helpful I'll turn it over.
Your next question comes from Gate Hodge day with Wells Fargo.
Good morning, Tom Mark Congratulations on a solid year.
Real quick on.
And I have a follow up but that's a business where I feel like maybe from the outside world and it felt like a little bit of a black box give and RPC had been fairly acquisitive.
Kind of and its existence.
And 1% volume growth came a little bit quicker than what we were thinking about give and even the headwinds on the more industrial side of the business. So can you talk about maybe with a little more granularity.
And where you're seeing I guess business wins, and then maybe how sustainable that that might be encouraging from our standpoint.
Yes, the first and foremost we continue to be thrilled.
With that acquisition, it's now part of Berry.
Our team is comprised of Berry people, who are focused on a common objective.
And frankly, the caliber of the organization that we acquired.
His exceptional on.
The team did an amazing job and what was arguably a difficult growth environment.
And to to optimize.
Profitability throughout the year and in the quarter with 1% growth.
We saw the benefits again of that and that strong stable portfolio around consumer non discretionary supporting food growth health care and we've we've talked about our goals and objectives around closed and dispensing solutions, we make and we are making terrific progress in that regard as well and other global business.
Where best practices can be shared between CP and AMCP International. So we're excited about this business and and clearly as you've seen some improvement.
In the in the economies, you've seen some improvement as well and in the industrial based businesses, but.
Really feel solid about that business that team.
And their outlook for 21.
This is a this is a true value.
Contributor for our company to serve global customers.
And the footprint and core capability and the DNA and that team.
We continue to be excited.
All right. Thanks, Thanks for that and then I guess real quick.
In terms of capital redeployment.
I don't know if you kind of addressed you talked about and elite side of the equation, but.
As you have visibility to be less than four times levered.
I would.
Would you envision maybe laying out a range for from the investment community I don't know some time and in the middle of 2021 and then.
Our acquisitions still part of the DNA and I would suspect that they are but just kind of any update or.
Framework, you can provide on what you'd be looking for up market.
Anything we do has always guided by whats going to maximize shareholder value and something that we talk to our board of directors about EPS.
Every single quarter, we're excited to be able to give a range between three athree nine by the end of the fiscal year as we get closer to that objective clearly will be and a better position to evaluate.
For 22 and beyond what what that what that expectation is in terms of.
Our commitments externally the marketplace and the reason I say that at that time, we'll have to evaluate what the economic circumstances are.
No what the conditions are the markets that we play will all factor into that decision, but feel really good that we've executed against that strategic objective of balance sheet improvement and a bad.
Faster pace than I think people expected.
And relative to.
M&A no thats clearly one of the components of Optionality that we have a we have a number of things that we can consider we can continue to pay down our debt. We can consider you know all the other type of capital allocations up to an including M&A, Ed and consideration, but that is something we review every single quarter with our board and.
It's a reasonable expectation you have as we get closer to this goal being in a better position at that time to talk further about it.
Thank you.
Your next question comes from and no just Shah with BMO capital markets.
Hi, good morning, everyone.
And it sounds like closures and dispensers continue to do really well and I believe you said and the pass that including RPC. It's now about a 2 billion dollar revenue business for you.
On one is that correct and then two are you thinking about further investment and that business.
It is correct, it's about a 2 billion dollar business and.
It's a component of where we're investing on capex because many of those products ultimately can support some of the mega trends that weve outlined in the past.
And I'd argue the portfolio has been strong whether it's food, whether it's health care related to our workloads dispensing solutions, but clearly dispensing and closures and the global opportunity that we we ultimately communicate quite often between North America and international groups to serve our global customers we will continue.
Invest and grow in that space for sure.
Your next question comes from Salvatore Tiano with Seaport Global.
Yes, Hi, a couple of questions from me on co some debt will be longer term mile earnings potential firstly on the coast and.
And makes it but can you elaborate there will be thought on this.
25 million a headwind from resins.
What does it and corporate in terms of raising price and mouth, Luke and also has there anything changed with regard to the RPC synergies I.
I think the target was 150 medium how should we think about these two items.
I'll answer the last one on Mark and talk about the assumptions on the resin side of it.
We maintain our guidance that we probably last time on RPC did it offensively, we feel we're in a really good spot in terms of delivering on that commitment, but more importantly, what what we believe is going to be a benefit for our company and just the opportunity for growth synergies on.
And our enabled by this global platform you know clearly we know what we saw in 2020, having a global value delivery capability in terms of 295 sites around the world gave us an amazing amount of agility.
Ultimately allow us to execute and really demonstrate from a global perspective, what we think is best in class speed to market capabilities, and we think thats only enhanced by CPI and we'll continue to take advantage of that to help support our organic growth objectives.
Certainly and 21 and beyond and.
The guidance includes all of the RASM changes through the last several months, which would be October and again, we have very efficient pass through so.
To the extent the resin market changes between October and the balance of the year.
I wouldn't expect that to be to be significant I'd on.
So the team did a nice job and 2020.
Making good progress in terms of terms and pass through mechanisms.
As Mark said this is a this is a pass through as debt before us, but we're in a really good position.
In terms of.
In terms of that especially with high utilization rates and and a richer pipeline and and again and really what what RPC is enabled is for berry to have a global marketplace and ultimately to procure a.
Key raw materials.
Perfect and just a little bit on a you know on.
B 22, it will be too early but.
As we tried to think about your long term free cash let me be the potential is it safe to say that based on the bridge you can see you have roughly 50 million of low hanging fruit of EBITDA growth in fiscal 22, or even without any volume or additional synergies and on the free cash flow how do we.
Full and do you think it's going to come down closer to what would be a more typical sustainable level and.
Would that be around 500 million and I guess.
Yes, I mean, we.
And we remain committed to growing our business, both topline and bottom line again low single digits.
We remain committed to doing that in terms of cash flow, we do still have some.
Integration related costs that are impacting.
21 that we would expect again to go and future years, and as we continue to pay off debt and we're continuing to reduce our AR.
Our interest cost which helped drive.
Further free cash flow generation.
Okay. Thank you very much.
Your next question comes from Phil Ng with Jefferies.
Hey, guys.
82 million of positive price cost spread and quarter was really impressive and it stepped up sharply from the last few quarters any way to kind of tease out whatever that improve and was perhaps upside on synergies on the good work you're doing on productivity and did you start seeing some resin headwinds are ready in the quarter.
Yes.
Component and that was certainly synergies.
Right part of that.
Mix again benefited our HMS business on the quarter.
And and productivity was strong and helps when now and the plan for fall and they've got volume.
Certainly and catalyst for productivity side and on your kind of the three big buckets.
Probably a little more towards the synergy side, if you're slicing and dicing and I think we gave.
Mix benefit and we estimate to be about $25 million.
On the balance being productivity.
Okay. So outside of mix it sounds like most of the gains you saw on the quarter was sustainable and maybe get a little headwind on resin to start the year that's.
That's great and in terms of your Cpis and EM segment, I mean, it's got a little more industrial exposure there any color on the cadence from a volume standpoint, and the quarter and how trends are shaking out in October and do you have any have you seen any impact from just your broader portfolio overall with the uptick we're seeing and koby cases, whether it's Europe and.
Yes.
So on industrial for both CPI, and and EM were improved and engineered materials. It's a it's largely a distribution base business, there and can always be a component of pre buy and in that space, but nonetheless, we saw really strong sequential improvement there from Q3 to Q4.
Sure.
You saw improvement and businesses like automotive.
In CP VI as well as.
Our automotive business in North America.
I think what's interesting is that does that in Europe, even with a a quote uptick and cobot cases.
You know, it's a different type of a shutdown and communities that are shutting down.
To a large extent most businesses continue to operate and.
And where if and in the previous period were you not deem and essential business those businesses literally shut down and that's not the case in terms of what's happened.
In the fourth quarter, and what's anticipated to happen here and in Q1.
But both businesses showed improvement on the industrial side and and.
As we hopefully we get closer to.
On some range and normalcy and those businesses should continue to.
To meet her up.
Okay, great. Thanks, a lot.
Your next question comes from Laurels cash.
And your Berg with credit Suisse.
Hi, Thank you just had a quick question.
In terms of the.
Guidance to EBITDA, you mentioned confident and number of times Thats, I mean, not more confidence confident and generation and EBITDA as opposed to just talking about free cash flow, which there are elements from you.
But you can kind of control.
But also on that free cash flow you called on Capex and 650 can you share with US what you expect for cash interest expense and cash taxes and other items that you have shared in the past and I.
Cash flow guidance.
Yes, and relative on this yes relative to the confidence for 21 like I said, we're exiting 2020 with a with a lot of momentum.
Each of the businesses have stronger pipelines going into 21.
And the level of execution is very high so I think given the capital investments that we've made over the last several years to position ourselves and faster growing market space is faster growing regions of the world you know with advantage products, all guided and centered around our focus on sustainability and puts us in a really good position. So.
Yes, we feel comfortable and confident that we'll deliver on the commitments that we've outlined for 21 on this call.
And with respect to Sameer.
And on the PML I mean, I think interest on the cash side.
And the 340 range.
For the year and taxes.
We continue to believe 25% is on.
Good effective tax rate for the company.
Consistent with past guidance, we provided.
Thank you.
Your next question comes from Jeff Zekauskas with JP Morgan.
Thanks, very much on two questions.
You made very nice working capital progress and that your receivables and inventories were down.
Payables looked like they were up on flat sales is there something unusual in that number.
But where is that a good number going forward such that next year or do you expect working capital benefit or detriment or port will be about the site.
Yes, I mean, as we as we talked about resin is a really efficient pass through so to the extent, there's inflation or deflation on RASM, obviously that changes, our working capital and higher receivables.
Our inventories, partially offset by higher payables.
And there were some increases late and the.
And the fiscal year that impact and that but the team again continues to.
Execute well on minimizing the working capital needs of the business and.
And those initiatives on stopping we're going to continue.
To drive improvements just as we have historically.
And our working capital efficiency.
So what's your base case that you're going to use working capital or.
Or.
Or non Arsenal is our goal is generally flat year over year to be able to offset the.
The growth that we see expect and the business to be offset with working capital efficiency.
Okay. Thanks to its target on anyway.
Thank you.
Your next question comes from Kyle White with Deutsche Bank.
Hi, good morning extinct question bit of and nuanced question I want to focus and on the price cost a little bit maybe I missed this mark, but if if I tried to adjust for for the synergies.
The resin cost timing and kind of the mix impact you're seeing on a year over year basis, I'm, just trying to get a sense of what you guys are assuming for inflationary things such as transportation coatings labors are you kind of expecting a neutral price pass on those things, where you're offsetting any inflation there with pricing.
Yes, the latter we expect productivity and price too.
Offset any inflation is I think you heard.
And the fiscal quarter, though most recently completed Q4.
On strong execution on that regard I was actually favorable.
Pretty significantly so.
We think.
Flat assumption is very achievable.
Okay. That's helpful. And then go into the free cash flow just curious why it was such a large range to $100 million versus an even smaller range on the EBITDA EPS is.
Is it mainly just any fluctuations on the working capital side with resin or.
Or anything else there.
Yes, I mean, obviously, we've got $50 million of.
Range for EBITDA, which would obviously fall to the cash flow.
The remaining balance is exactly what you said.
Working capital and how resin ultimately cycles through the year can can impact on the ending working capital number.
And I guess, if I could follow up than it is to me it sounded like on the previous question you were targeting flat, but I don't know what are you actually targeting and your assumption for your free cash flow this year.
Oh, yes.
Yeah, we target flat every year the assumption for next year is essentially flat, we've got a small use and I think it's around 50 million for integration related costs and working capital in the aggregate.
Okay. That's helpful I'll turn it over good luck in the year.
Thanks.
Your next question is a follow up from Iran, Viswanathan with RBC capital markets.
Hi, Thanks for taking my follow up guys that just one just wanted to ask about and.
The potential on the part of your portfolio that is potentially disadvantage and what are your assumptions for food service and industrial and next year within that 2% volume growth. Thanks.
Yes, so the majority of our foodservice business is actually QSR I mean, we certainly have some products that.
Service and.
In dining but the.
We're over weighted towards quick serve restaurants, and we're anticipating those businesses to continue to operate and in fiscal 2021.
To that where we're.
And the relationships that we have from a QSR perspective it is a.
We think we're in a good spot it continues to be a preferred means for people to dine out.
Quote unquote, albeit that they're getting their food through a a drive up window and the number of QSR is that are actually preparing.
Their restaurants and considering models that are.
Dr. true only I'm only further benefits.
Our current mix of business inside that space and again.
The product that we sell there continue to have the attributes that.
They offer clarity.
And and finished and security as well and it's up I continue to be very steady space for us as we saw on engineered materials and CPI.
As you see some improvement in terms of the reopening of the economies you clearly begin to see the industrial businesses continued to improve automotive has had strong recovery and both engineered materials is or I should say, EBITDA, HHS and CPI and and we.
Back that fit to gradually improve over time throughout the course of a 21.
Thanks.
And your final question is a follow up from George Staphos with Bank of America.
Hi, guys, sorry for coming in here linked to finish up but question on on capital allocation really acquisitions.
So you know as we heard today and really the last couple of quarters, Tom and Mark the company seems to be growing at least as well if not more quickly and the industry you seem to be very pumped about your sustainability products and would probably put them here and putting words in your mouth.
Lease and line if not ahead of what your peer set would be offering.
And you're doing quite well on productivity. So when you look at making acquisitions doesn't that suggest that the bar has to get.
Progressively higher.
What kind of acquisition would you be looking towards.
I know there are no guarantees and life, but.
Would it be smaller and more technologically driven are there larger deals out there that would be.
The transformational at this juncture and is there any way you could have us think about what the right return you would be targeting.
Presumably higher and higher based on the fact that you don't really need to seem to need to many acquisitions given your performance last few quarters, thanks and good luck.
And the year.
Thanks George.
The latter probably is true but.
But clearly we will continue to evaluate those aspects that can drive and maximize shareholder value and anything that we can do that we feel we can execute and deliver against that will allow us to have a a better offering to meet the needs of our end customers and our shareholders are.
<unk> opportunities that we would we would take strong consideration in and around we are pleased with how our teams and I would be remiss if I didn't thank our global organization for the way they've executed.
And the way they are executed and their commitment around around productivity and.
Around around growth around operational excellence and around driving continued benefits and.
Around cost reduction via.
And sustainable solutions so.
Feel really bullish on that regard a suffice to say pockets and areas of opportunity to enhance our position around health and wellness.
On food safety and preservation and.
Around E commerce, and sustainability and it will continue to be areas of opportunity for us to continue to grow and expand our business.
Now I'll turn the call back over to Tom for any closing remarks. Thank you very much on thank everybody for their interest and I I'd be remiss if the business is exiting 2020 with very strong.
Momentum pipelines that are robust and it's given us a high degree of confidence and meeting or exceeding our growth outlook and conviction that we've that we've talked about and as an organization, we're continuing to pivot to and investing in and around higher growth regions and market areas. Just as we have around health care and premium hygiene stacking E com.
Yes, and closures and dispensing solutions we've.
We blew believed that our global platform is offering best in class speed to market and.
And with global capability, and and lastly, the creation for Berry of our global health care rigid packaging business medical device platform. We believe will provide a business that's going to generate higher growth for many years to come. Thanks for your interest and our company look forward to our next call.
Ladies and gentlemen, thank you again for joining US today. This concludes today's conference call you may now disconnect.
[music].